Yandong Bian, MD in Boston, MA - Medicare Ophthalmology

Yandong Bian, MD is a medicare enrolled "Ophthalmology" physician in Boston, Massachusetts. Her current practice location is 243 Charles St, Boston, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (617) 573-4443.

Yandong Bian is licensed to practice in Massachusetts (license number 1014121) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1275093064.

Contact Information

	Yandong Bian, MD
	243 Charles St, Boston, MA 02114-3096
	(617) 573-4443
	Not Available

Physician's Profile

Full Name	Yandong Bian
Gender	Female
Speciality	Ophthalmology
Location	243 Charles St, Boston, Massachusetts
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1275093064
Provider Enumeration Date: 03/20/2019
Last Update Date: 07/07/2023

Medicare PECOS Information:

PECOS PAC ID: 5193143824
Enrollment ID: I20230602000506

Medical Identifiers

Medical identifiers for Yandong Bian such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275093064	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	1014121 (Massachusetts)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Yandong Bian allows following entities to bill medicare on her behalf.

Entity Name	Massachusetts Eye And Ear Associates, Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123

News Archive

Mutations in phosphatase Wip1 could be a new target for treating cancer

Researchers have uncovered mutations in the phosphatase Wip1 that enable cancer cells to foil the tumor suppressor p53, according to a study in The Journal of Cell Biology. The results could provide a new target for the treatment of certain cancers.

First Edition: June 6, 2011

Kaiser Health News staff writer Christopher Weaver reports: "Short on cash and time, officials in California and at least a dozen other states have turned to philanthropies to help pay for the extra work required under the federal health law".

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3's next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Thursday published Issue 199 of its "Global Fund Observer."

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Yandong Bian is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Yandong Bian, MD 243 Charles St, Boston, MA 02114-3096 Ph: (617) 573-4443	Yandong Bian, MD 243 Charles St, Boston, MA 02114-3096 Ph: (617) 573-4443

News Archive

Mutations in phosphatase Wip1 could be a new target for treating cancer

First Edition: June 6, 2011

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Thursday published Issue 199 of its "Global Fund Observer."

Ophthalmology Doctors in Boston, MA

Dr. Maan Sulaiman A Alkharashi, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 4, Boston, MA 02115 Phone: 857-523-6040
Daniel J Townsend, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 175 Cambridge St, C/o Prooptical, Boston, MA 02114 Phone: 617-723-3937 Fax: 617-523-5006
Daniel Robert Lefebvre, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, 10th Floor -- Ophthalmic Plastic Surgery, Boston, MA 02114 Phone: 617-523-7900
Dr. Seanna Rae Grob, MD, MAS Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900
Ravi Parikh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3288
Michael V Boland, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3611
Dr. Parvathy A Pillai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-647-1226 Fax: 617-573-3181

Yandong Bian, MD - Medicare Ophthalmology in Boston, MA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Mutations in phosphatase Wip1 could be a new target for treating cancer

First Edition: June 6, 2011

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

Aidspan publishes new issue of 'Global Fund Observer'

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Mutations in phosphatase Wip1 could be a new target for treating cancer

First Edition: June 6, 2011

M3 USA, Bristol-Myers Squibb to launch next-generation eLearning and eMarketing solution

Aidspan publishes new issue of 'Global Fund Observer'

Ophthalmology Doctors in Boston, MA